Origent Data Sciences, Inc., and Cytokinetics, Inc., announced a new research partnership to further refine and validate an Origent computer model to predict the progression of amyotrophic lateral sclerosis (ALS) in patients — a progression that widely varies, making effective clinical trials difficult and costly — by leveraging data from previous and…
In this video from the Mayo Clinic, watch Dr. Leonard Petrucelli talk about how the clinic has been studying and researching for a new development of a mouse model “that exhibits the features linked with the most common genetic form of ALS and frontotemporal dementia.” Read…
AB Science announced that its Phase 2/3 clinical trial evaluating masitinib, the company’s lead compound to treat amyotrophic lateral sclerosis (ALS) patients, has met its primary objective. The ongoing study is currently recruiting participants and expects to finish in June 2017. “The positive outcome of this study in ALS is a significant milestone…
In this ALS Association video watch specialists in ALS care explore the choices available for respiratory support. Learn more about ALS here: https://bit.ly/ALSNewsToday ALS News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is…
Neuraltus Pharmaceuticals announced that it will initiate a second Phase 2 clinical trial of its investigational drug candidate NP001 for the treatment of amyotrophic lateral sclerosis (ALS), with the intent of confirming positive earlier findings in patients with elevated levels of baseline inflammation and further evaluating the drug’s efficacy. Inflammation is thought to be a…
Leaders in the field of induced pluripotent stem cell (iPSC) – a technology that can help derive motor neurons from people who suffer from amyotrophic lateral sclerosis (ALS) – have published a cutting-edge review, identifying advances and challenges in ALS modeling ability and calling for the development and adoption of rigorous criteria…
1. Herantis’ Potential ALS Treatment, CDNF, Recommended for Orphan Drug Status by EMA Herantis Pharma announced that it has received a positive opinion from the European Medicines Agency’s Committee for Orphan Medicinal Products (COMP) on…
In this cauchilab video, “Cyrielle Delmas meets graduate Rebecca Borg at her Dr. Cauchi’s lab at the University of Malta to talk about her research on ways to cure ALS/motor neuron disease.” Learn more about Borg’s research here: https://www.researchgate.net/profile/Rebecca_Borg2 Learn more about ALS here: https://bit.ly/ALSNewsToday…
https://www.youtube.com/watch?v=XJE8OxUn0d4 In this video by the Adaptive Canuck ALS Foundation, learn more about their work with families living with ALS and with adult stem cell research. Learn more about ALS here: https://bit.ly/ALSNewsToday…
ALS, or amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease, is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. A-myo-trophic comes from the Greek language. “A” means no. “Myo” is referring to the muscle, and “Trophic” means nourishment –…
